Advertisement

Laryngeal Manifestations of Ehlers-Danlos Syndrome

Published:November 21, 2022DOI:https://doi.org/10.1016/j.jvoice.2022.10.018

      Summary

      Objectives

      The identification of voice and airway manifestations of Ehlers-Danlos Syndrome (EDS), diagnoses, and potential treatment modalities.

      Study Design

      Single institution retrospective case series.

      Methods

      We examined all patients presenting to our institution over a span of 10 years with a history of EDS or who were subsequently diagnosed with EDS after their evaluation. Demographic and clinical data were collected.

      Results

      Four patients were identified with an underlying diagnosis of EDS. All four patients were heavy voice users. All four patients had history and/or stroboscopy findings suggesting vocal hyperfunction, which we suspect is due to EDS-related hypermobility of the cricoarytenoid joint or fragility of the superficial lamina propria. Two patients also had respiratory symptoms – one with respiratory muscle weakness and sensation loss and one with inducible laryngeal obstruction. All patients were treated with voice therapy with subsequent improvement in their symptoms.

      Conclusions

      Patients with EDS may present to laryngology clinics with symptoms of dysphonia or dyspnea secondary to their underlying condition. Voice therapy is a low-risk and potentially beneficial treatment in this patient population.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Voice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Parapia LA
        • Jackson C.
        Ehlers-Danlos syndrome–a historical review.
        Br J Haematol. 2008; 141: 32-35
        • Malfait F
        • Castori M
        • Francomano CA
        • et al.
        The Ehlers-Danlos syndromes.
        Nat Rev Dis Primers. 2020; 6: 64
        • Birchall MA
        • Lam CM
        • Wood G.
        Throat and voice problems in Ehlers-Danlos syndromes and hypermobility spectrum disorders.
        Am J Med Genet C Semin Med Genet. 2021; 187: 527-532
        • Castori M
        • Camerota F
        • Celletti C
        • et al.
        Natural history and manifestations of the hypermobility type Ehlers-Danlos syndrome: a pilot study on 21 patients.
        Am J Med Genet A. 2010; 152A: 556-564
        • Arulanandam S
        • Hakim AJ
        • Aziz Q
        • et al.
        Laryngological presentations of Ehlers-Danlos syndrome: case series of nine patients from two London tertiary referral centres.
        Clin Otolaryngol. 2017; 42: 860-863
        • Rimmer J
        • Giddings CE
        • Cavalli L
        • et al.
        Dysphonia–a rare early symptom of Ehlers–Danlos syndrome?.
        Int J Pediatr Otorhinolaryngol. 2008; 72: 1889-1892
        • Desuter G
        • Gardiner Q
        • Dahan K.
        Laryngeal signs of Ehlers Danlos syndrome in an adult: the first case reported.
        Otolaryngol Head Neck Surg. 2009; 141: 428-429
        • Sanz L
        • Sistiaga JA
        • Lara AJ
        • et al.
        The prevalence of dysphonia, its association with immunomediated diseases and correlation with biochemical markers.
        J Voice. 2012; 26: 148-153
        • Liu ZW
        • Masterson LM
        • Srouji IA
        • et al.
        Voice symptoms in patients with autoimmune disease: a cross-sectional epidemiological study.
        Otolaryngol Head Neck Surg. 2012; 147: 1108-1113
        • Pierce JL
        • Tanner K
        • Merrill RM
        • et al.
        Voice disorders in Sjogren's syndrome: prevalence and related risk factors.
        Laryngoscope. 2015; 125: 1385-1392
        • Mao VH
        • Abaza M
        • Spiegel JR
        • et al.
        Laryngeal myasthenia gravis: report of 40 cases.
        J Voice. 2001; 15: 122-130
        • Bhattacharyya N.
        The prevalence of voice problems among adults in the United States.
        Laryngoscope. 2014; 124: 2359-2362
        • Hillman RE
        • Stepp CE
        • Van Stan JH
        • et al.
        An updated theoretical framework for vocal hyperfunction.
        Am J Speech Lang Pathol. 2020; 29: 2254-2260
        • Chohan K
        • Mittal N
        • McGillis L
        • et al.
        A review of respiratory manifestations and their management in Ehlers-Danlos syndromes and hypermobility spectrum disorders.
        Chron Respir Dis. 2021; 1814799731211025313